XML 22 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Consolidated Statement of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Cash flows (used in) provided by operating activities:      
Net income $ 219,986 $ 193,031 $ 157,876
Adjustments to reconcile net income to net cash provided by operating activities:      
Amortization of discount/premium and PIK (64,269) (48,062) (10,679)
Amortization of deferred financing costs 11,186 6,669 4,607
Equity-based compensation 8,809 10,977 4,464
Unrealized (gain) loss on securities 0 (37,165) 26,099
Provision for loan losses and impairment 20,000 5,000 15,000
Loss from unconsolidated joint venture 0 2,259 97
Foreign currency (gain) loss 29,617 (18,645) 28,790
Unrealized (gain) loss on derivative instruments (29,345) 11,523 (2,608)
Loss on early extinguishment of debt 2,573 0 0
Realized (gain) loss on derivative instruments 0 289 (28,552)
Realized (gain) loss on sale of assets 0 42,693 (3,834)
Bargain purchase gain 0 0 (40,021)
Changes in operating assets and liabilities:      
Proceeds received from PIK 75,652 0 5,004
Other assets (10,198) (5,192) (25,579)
Loan proceeds held by servicer 0 (6,306) 0
Accounts payable, accrued expenses and other liabilities 317 (3,351) (8,496)
Payable to related party 1,636 1,153 1,718
Net cash (used in) provided by operating activities 265,964 154,873 123,886
Cash flows used in investing activities:      
New funding of commercial mortgage loans (1,849,100) (1,136,252) (625,800)
Add-on funding of commercial mortgage loans (131,718) (82,240) (224,611)
New funding of subordinate loans (220,809) (497,629) (209,119)
Add-on funding of subordinate loans (149,238) (112,637) (76,199)
Proceeds and payments received on commercial mortgage loans 675,140 218,002 205,226
Proceeds and payments received on subordinate loans 610,051 376,727 117,149
Origination and exit fees received on commercial mortgage and subordinate loans 41,822 27,904 12,500
Funding of unconsolidated joint venture 0 (726) (362)
Funding of other assets 0 (1,379) (1,640)
Proceeds (payments) on settlements of derivative instruments 0 (201) 28,552
Increase (decrease) in collateral held related to derivative contracts 24,930 (4,952) 2,480
Payments and proceeds received on securities 0 468,171 140,228
Proceeds from sale of investments in unconsolidated joint venture 0 24,498 0
Payments received on other assets 0 0 132
Net cash (used in) provided by investing activities (998,922) (720,714) 1,066,529
Cash flows from financing activities:      
Proceeds from issuance of common stock 275,879 279,816 178,185
Redemption of preferred stock 0 (116,990) 0
Payment of offering costs (484) (924) (406)
Proceeds from secured debt arrangements 2,153,846 1,239,515 721,992
Repayments of secured debt arrangements (1,580,343) (1,045,614) (501,200)
Proceeds from issuance of Notes 226,550 343,275 0
Exchanges and conversions of Notes (40,461) 0 0
Repayments of participations sold 0 (85,081) (4,372)
Payment of deferred financing costs (15,337) (14,254) (4,017)
Dividends on common stock (227,217) (183,877) (132,213)
Dividends on preferred stock (27,340) (35,807) (27,956)
Net cash (used in) provided by financing activities 765,093 380,059 (1,024,504)
Net increase (decrease) in cash and cash equivalents 32,135 (185,782) 165,911
Cash, cash equivalents, and restricted cash, beginning of period 77,671 263,453 97,542
Cash, cash equivalents, and restricted cash, end of period 109,806 77,671 263,453
Supplemental disclosure of cash flow information:      
Interest paid 97,880 55,835 52,708
Supplemental disclosure of non-cash financing activities:      
Exchange of Notes for common stock 180,016 0 0
Dividend declared, not yet paid 69,033 56,576 51,278
Offering costs payable 0 0 279
Loan proceeds held by servicer 1,000 302,756 0
AMTG [Member]      
Cash flows used in investing activities:      
Proceeds from sale of AMTG assets, net 0 0 1,508,198
ARI Investment in AMTG, net of cash acquired 0 0 189,795
Cash flows from financing activities:      
Repayments of secured debt arrangements 0 0 (1,254,517)
Supplemental disclosure of non-cash financing activities:      
Fair value of assets acquired from AMTG 0 0 1,936,260
Fair value of liabilities assumed from AMTG 0 0 (1,285,183)
Fair value of common stock issued to AMTG 0 0 218,397
Fair value of preferred stock issued to AMTG $ 0 $ 0 $ 172,500